Litigation Details for United Therapeutics Corporation v. ANI Pharmaceuticals, Inc. (D. Del. 2021)
✉ Email this page to a colleague
United Therapeutics Corporation v. ANI Pharmaceuticals, Inc. (D. Del. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-04-01 |
| Court | District Court, D. Delaware | Date Terminated | 2022-05-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | ANI PHARMACEUTICALS, INC. | ||
| Patents | 7,417,070; 7,544,713; 8,252,839; 8,349,892; 8,410,169; 8,747,897; 9,050,311; 9,278,901; 9,393,203; 9,422,223; 9,593,066; 9,604,901 | ||
| Attorneys | Karen Elizabeth Keller | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in United Therapeutics Corporation v. ANI Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for United Therapeutics Corporation v. ANI Pharmaceuticals, Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-04-01 | 1 | Complaint | seq., involving United States Patent Nos. 7,417,070 (“the ’070 patent”) (attached as Exhibit A hereto…the ’070 patent, the ’713 patent, ’839 patent, the ’892 patent, the ’169 patent, the ’897 patent, the ’…the ’070 patent, the ’713 patent, ’839 patent, the ’892 patent, the ’169 patent, the ’897 patent, the ’…the ’070 patent, the ’713 patent, ’839 patent, the ’892 patent, the ’169 patent, the ’897 patent, the ’…the ’070 patent, the ’713 patent, ’839 patent, the ’892 patent, the ’169 patent, the ’897 patent, the ’ | External link to document |
| 2021-06-23 | 16 | Scheduling Order - Patent | United States Patent Nos. 7,417,070 (“the ’070 patent”), 7,544,713 (“the ’713 patent”), 8,252,839 (“…(“the ’839 patent”), 8,349,892 (“the ’892 patent”), 8,410,169 (“the ’169 patent”), 8,747,897 (“the ’897…’897 patent”), 9,050,311 (“the ’311 patent”), 9,278,901 (“the ’901 patent”), 9,393,203 (“the ’203 patent…United States Patent Nos. 9,593,066 (“the ’066 patent”) and 9,604,901 (“the ’4901 patent”) are asserted…patent”), and 9,422,223 (“the ’223 patent”) Case 1:21-cv-00489-RGA Document 16 Filed 06/23/21 Page 4 of | External link to document |
| 2022-05-26 | 48 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,417,070 B2; 7,544,713 B2; 8,252,839… 2021 26 May 2022 1:21-cv-00489 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
